Literature DB >> 22555458

miR-205 regulates basement membrane deposition in human prostate: implications for cancer development.

P Gandellini1, V Profumo, A Casamichele, N Fenderico, S Borrelli, G Petrovich, G Santilli, M Callari, M Colecchia, S Pozzi, M De Cesare, M Folini, R Valdagni, R Mantovani, N Zaffaroni.   

Abstract

The basement membrane (BM) is a layer of specialized extracellular matrix that surrounds normal prostate glands and preserves tissue integrity. Lack or discontinuity of the BM is a prerequisite for tumor cell invasion into interstitial spaces, thus favoring metastasis. Therefore, BM maintenance represents a barrier against cancer development and progression. In the study, we show that miR-205 participates in a network involving ΔNp63α, which is essential for maintenance of the BM in prostate epithelium. At the molecular level, ΔNp63α is able to enhance miR-205 transcription by binding to its promoter, whereas the microRNA can post-transcriptionally limit the amount of ΔNp63α protein, mostly by affecting ΔNp63α proteasomal degradation rather than through a canonical miRNA/target interaction. Functionally, miR-205 is able to control the deposition of laminin-332 and its receptor integrin-β4. Hence, pathological loss of miR-205, as widely observed in prostate cancer, may favor tumorigenesis by creating discontinuities in the BM. Here we demonstrate that therapeutic replacement of miR-205 in prostate cancer (PCa) cells can restore BM deposition and 3D organization into normal-like acinar structures, thus hampering cancer progression.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22555458      PMCID: PMC3469086          DOI: 10.1038/cdd.2012.56

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  39 in total

1.  Diagnostic utility of immunohistochemical staining for p63, a sensitive marker of prostatic basal cells.

Authors:  Michael H Weinstein; Sabina Signoretti; Massimo Loda
Journal:  Mod Pathol       Date:  2002-12       Impact factor: 7.842

2.  Chromatin immunoprecipitation (ChIP) on chip experiments uncover a widespread distribution of NF-Y binding CCAAT sites outside of core promoters.

Authors:  Anna Testa; Giacomo Donati; Pearlly Yan; Francesca Romani; Tim H-M Huang; M Alessandra Viganò; Roberto Mantovani
Journal:  J Biol Chem       Date:  2005-01-11       Impact factor: 5.157

3.  p63 regulates commitment to the prostate cell lineage.

Authors:  Sabina Signoretti; Maira M Pires; Meghan Lindauer; James W Horner; Chiara Grisanzio; Sonya Dhar; Pradip Majumder; Frank McKeon; Philip W Kantoff; William R Sellers; Massimo Loda
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-28       Impact factor: 11.205

4.  Basal epithelial stem cells are efficient targets for prostate cancer initiation.

Authors:  Devon A Lawson; Yang Zong; Sanaz Memarzadeh; Li Xin; Jiaoti Huang; Owen N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-25       Impact factor: 11.205

Review 5.  Towards the definition of prostate cancer-related microRNAs: where are we now?

Authors:  Paolo Gandellini; Marco Folini; Nadia Zaffaroni
Journal:  Trends Mol Med       Date:  2009-08-27       Impact factor: 11.951

6.  Low-density Taqman miRNA array reveals miRNAs differentially expressed in prostatic stem cells and luminal cells.

Authors:  Li Zhang; Wenping Zhao; Joseph M Valdez; Chad J Creighton; Li Xin
Journal:  Prostate       Date:  2010-02-15       Impact factor: 4.104

7.  Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma.

Authors:  Annika Schaefer; Monika Jung; Hans-Joachim Mollenkopf; Ina Wagner; Carsten Stephan; Florian Jentzmik; Kurt Miller; Michael Lein; Glen Kristiansen; Klaus Jung
Journal:  Int J Cancer       Date:  2010-03-01       Impact factor: 7.396

Review 8.  Defining the role of laminin-332 in carcinoma.

Authors:  Cherise M Guess; Vito Quaranta
Journal:  Matrix Biol       Date:  2009-08-15       Impact factor: 11.583

9.  p51/p63 Controls subunit alpha3 of the major epidermis integrin anchoring the stem cells to the niche.

Authors:  Shun-Ichi Kurata; Takeshi Okuyama; Motonobu Osada; Tatsuya Watanabe; Yoshiya Tomimori; Shingo Sato; Aki Iwai; Tsutomu Tsuji; Yoji Ikawa; Iyoko Katoh
Journal:  J Biol Chem       Date:  2004-09-12       Impact factor: 5.157

10.  deltaEF1 repressor controls selectively p53 family members during differentiation.

Authors:  Giulia Fontemaggi; Aymone Gurtner; Alexander Damalas; Antonio Costanzo; Yujiro Higashi; Ada Sacchi; Sabrina Strano; Giulia Piaggio; Giovanni Blandino
Journal:  Oncogene       Date:  2005-11-10       Impact factor: 9.867

View more
  41 in total

Review 1.  MicroRNAs in prostate cancer: From function to biomarker discovery.

Authors:  Ahmed A Moustafa; Hogyoung Kim; Rasha S Albeltagy; Ola H El-Habit; Asim B Abdel-Mageed
Journal:  Exp Biol Med (Maywood)       Date:  2018-06

Review 2.  Nanoways to overcome docetaxel resistance in prostate cancer.

Authors:  Aditya Ganju; Murali M Yallapu; Sheema Khan; Stephen W Behrman; Subhash C Chauhan; Meena Jaggi
Journal:  Drug Resist Updat       Date:  2014-04-05       Impact factor: 18.500

3.  The p63 protein isoform ΔNp63α inhibits epithelial-mesenchymal transition in human bladder cancer cells: role of MIR-205.

Authors:  Mai N Tran; Woonyoung Choi; Matthew F Wszolek; Neema Navai; I-Ling C Lee; Giovanni Nitti; Sijin Wen; Elsa R Flores; Arlene Siefker-Radtke; Bogdan Czerniak; Colin Dinney; Michelle Barton; David J McConkey
Journal:  J Biol Chem       Date:  2012-12-13       Impact factor: 5.157

Review 4.  MicroRNAs targeting prostate cancer stem cells.

Authors:  Yu-Xiang Fang; Yun-Li Chang; Wei-Qiang Gao
Journal:  Exp Biol Med (Maywood)       Date:  2015-05-12

Review 5.  Dissecting the role of microRNAs in prostate cancer metastasis: implications for the design of novel therapeutic approaches.

Authors:  Valentina Doldi; Marzia Pennati; Barbara Forte; Paolo Gandellini; Nadia Zaffaroni
Journal:  Cell Mol Life Sci       Date:  2016-03-12       Impact factor: 9.261

6.  miR-205 hinders the malignant interplay between prostate cancer cells and associated fibroblasts.

Authors:  Paolo Gandellini; Elisa Giannoni; Anna Casamichele; Maria Letizia Taddei; Maurizio Callari; Claudia Piovan; Riccardo Valdagni; Marco Alessandro Pierotti; Nadia Zaffaroni; Paola Chiarugi
Journal:  Antioxid Redox Signal       Date:  2013-09-17       Impact factor: 8.401

7.  MicroRNA-205 suppresses the oral carcinoma oncogenic activity via down-regulation of Axin-2 in KB human oral cancer cell.

Authors:  Jae-Sung Kim; Sun-Young Park; Seul Ah Lee; Min-Gyeong Park; Sun-Kyoung Yu; Myoung-Hwa Lee; Mi-Ra Park; Su-Gwan Kim; Ji-Su Oh; Sook-Young Lee; Chun Sung Kim; Heung-Joong Kim; Hong Sung Chun; Jin-Soo Kim; Sung-Min Moon; Do Kyung Kim
Journal:  Mol Cell Biochem       Date:  2013-10-29       Impact factor: 3.396

8.  Renal epithelial miR-205 expression correlates with disease severity in a mouse model of congenital obstructive nephropathy.

Authors:  Michael E Wilhide; James D Feller; Birong Li; Ahmad Z Mohamed; Brian Becknell; Ashley R Jackson; Kirk M McHugh; Susan E Ingraham
Journal:  Pediatr Res       Date:  2016-06-07       Impact factor: 3.756

Review 9.  MicroRNAs as Epigenetic Determinants of Treatment Response and Potential Therapeutic Targets in Prostate Cancer.

Authors:  Valentina Doldi; Rihan El Bezawy; Nadia Zaffaroni
Journal:  Cancers (Basel)       Date:  2021-05-14       Impact factor: 6.639

10.  Comprehensive microRNA Profiling of Prostate Cancer.

Authors:  Beatriz A Walter; Vladimir A Valera; Peter A Pinto; Maria J Merino
Journal:  J Cancer       Date:  2013-05-09       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.